{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:10:48Z","timestamp":1784257848064,"version":"3.55.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T00:00:00Z","timestamp":1617408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Serum sickness-like reaction (SSLR) is an acute inflammatory condition affecting predominantly children. The pathophysiology remains unclear, but drugs are considered the main trigger.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>The aim of this study was to describe the clinical and laboratory features, triggers, and treatment modalities in children diagnosed with SSLR.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a 10-year retrospective cohort study including all paediatric patients (0 to 18 years old) with query SSLR referred to the Adverse Drug Reactions Clinic at the Children\u2019s Hospital of Western Ontario. Diagnostic criteria included acute skin rash plus joint inflammation with or without fever.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We included 83 patients (47 females). Age ranged from 11 months to 12 years (mean 3.2 years). Amoxicillin was the trigger in 82.7% of patients. The mean time between the exposure to the triggering drug and the development of the symptoms was 8.5 days. Urticaria-like and Erythema multiforme-like lesions were present in 35% and 38.5% of the cases, respectively. Joint inflammation affecting hands\/feet was present in 60%. Pruritus, lip\/eye swelling, and fever were reported in 33, 31, and 45% of patients, respectively. The lymphocyte toxicity assay (LTA) showed incremental T-cell toxicity in 32 of 34 patients. Children that received treatment with antihistamines\/nonsteroidal anti-inflammatory drugs (NSAIDs) plus oral steroids had a mean recovery time shorter than those treated only with antihistamines\/NSAIDs (6 versus 8 days; P=0.09).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In our study, SSLR was mostly triggered by amoxicillin and had a mean time presentation of 8.5 days. Further prospective and well-conducted studies are needed.<\/jats:p><\/jats:sec>","DOI":"10.1093\/pch\/pxab003","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T14:52:51Z","timestamp":1617720771000},"page":"428-435","source":"Crossref","is-referenced-by-count":24,"title":["Paediatric serum sickness-like reaction: A 10-year retrospective cohort study"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8597-5485","authenticated-orcid":false,"given":"Blanca R","family":"Del Pozzo-Maga\u00f1a","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Children\u2019s Hospital of Western Ontario, London, Ontario, Canada"},{"name":"Division of Clinical Pharmacology, Western University and London Health Sciences Centre, London Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awatif","family":"Abuzgaia","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Children\u2019s Hospital of Western Ontario, London, Ontario, Canada"},{"name":"Division of Clinical Pharmacology, Western University and London Health Sciences Centre, London Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Murray","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Children\u2019s Hospital of Western Ontario, London, Ontario, Canada"},{"name":"Division of Clinical Pharmacology, Western University and London Health Sciences Centre, London Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Rieder","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Children\u2019s Hospital of Western Ontario, London, Ontario, Canada"},{"name":"Division of Clinical Pharmacology, Western University and London Health Sciences Centre, London Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Lazo-Langner","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Western Ontario, London, Ontario, Canada"},{"name":"Department of Epidemiology and Biostatistics, University of Western Ontario, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,3]]},"reference":[{"issue":"3","key":"2021111108254856100_CIT0001","article-title":"Severe serum sickness-like reaction: Challenges in diagnosis and management","volume":"6","author":"De Schryver S","year":"2015","journal-title":"J C Exp Dermatol Res"},{"issue":"3","key":"2021111108254856100_CIT0002","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1081-1206(10)63308-X","article-title":"Severe serum sickness-like reaction to oral penicillin drugs: Three case reports","volume":"86","author":"Tatum","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"2021111108254856100_CIT0003","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1440-1754.2003.00267.x","article-title":"Adverse skin and joint reactions associated with oral antibiotics in children: The role of cefaclor in serum sickness-like reactions","volume":"39","author":"King","year":"2003","journal-title":"J Paediatr Child Health"},{"issue":"5","key":"2021111108254856100_CIT0004","first-page":"395","article-title":"Serum sickness-like reactions","volume":"69","author":"Yerushalmi","year":"2002","journal-title":"Cutis"},{"issue":"5","key":"2021111108254856100_CIT0005","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s10067-017-3777-4","article-title":"Demographic and clinical characteristics of patients with serum sickness-like reaction","volume":"37","author":"Yorulmaz","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"4","key":"2021111108254856100_CIT0006","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0973-3698(11)60203-3","article-title":"Clinical and laboratory profile of serum sickness-like reaction in children","volume":"6","author":"Shiari","year":"2011","journal-title":"Indian J Rheumatol"},{"issue":"5","key":"2021111108254856100_CIT0007","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1128\/AAC.34.5.904","article-title":"Serum sickness-like illness associated with ciprofloxacin","volume":"34","author":"Slama","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2021111108254856100_CIT0008","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1046\/j.1440-1754.2001.00632.x","article-title":"Serum sickness-like reaction to cefaclor","volume":"37","author":"Isaacs","year":"2001","journal-title":"J Paediatr Child Health"},{"issue":"4","key":"2021111108254856100_CIT0009","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1345\/aph.1D291","article-title":"Serum sickness-like reaction associated with griseofulvin","volume":"38","author":"Colton","year":"2004","journal-title":"Ann Pharmacother"},{"issue":"6","key":"2021111108254856100_CIT0010","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/jcpt.12448","article-title":"Probable metronidazole induced serum sickness-like reaction in a paediatric patient","volume":"41","author":"VanCleave","year":"2016","journal-title":"J Clin Pharm Ther"},{"issue":"5","key":"2021111108254856100_CIT0011","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00004583-200405000-00001","article-title":"Serum sickness-like reaction and bupropion","volume":"43","author":"Waibel","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"2021111108254856100_CIT0012","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/dth.12103","article-title":"Urticaria mimickers in children","volume":"26","author":"Mathur","year":"2013","journal-title":"Dermatol Ther"},{"issue":"5","key":"2021111108254856100_CIT0013","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF03256387","article-title":"Predictive value of the lymphocyte toxicity assay in the diagnosis of drug hypersensitivity syndrome","volume":"14","author":"Elzagallaai","year":"2010","journal-title":"Mol Diagn Ther"},{"issue":"4","key":"2021111108254856100_CIT0014","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/bcp.12505","article-title":"In vitro testing for diagnosis of idiosyncratic adverse drug reactions: Implications for pathophysiology","volume":"80","author":"Elzagallaai","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"2021111108254856100_CIT0015","article-title":"Pathogenesis of Beta-lactam-induced serum sickness-like reaction: The potential role of reactive drug metabolites","author":"Elzagallaai","year":"2020"},{"issue":"6","key":"2021111108254856100_CIT0016","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/fampra\/cmy033","article-title":"Requests for new oral antibiotic prescriptions in children within 2 days: A Norwegian population-based study","volume":"35","author":"Bergene","year":"2018","journal-title":"Fam Pract"},{"issue":"2","key":"2021111108254856100_CIT0017","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/02813432.2017.1333321","article-title":"Clinical indications for antibiotic use in Danish general practice: Results from a nationwide electronic prescription database","volume":"35","author":"Aabenhus","year":"2017","journal-title":"Scand J Prim Health Care"},{"issue":"3","key":"2021111108254856100_CIT0018","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1542\/peds.2013-2903","article-title":"Recent trends in outpatient antibiotic use in children","volume":"133","author":"Vaz","year":"2014","journal-title":"Pediatrics"},{"issue":"2","key":"2021111108254856100_CIT0019","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1542\/peds.80.2.270","article-title":"Adverse reactions reported following receipt of Haemophilus influenzae type b vaccine: An analysis after 1 year of marketing","volume":"80","author":"Milstien","year":"1987","journal-title":"Pediatrics"},{"issue":"3","key":"2021111108254856100_CIT0020","first-page":"AB6","article-title":"Serum sickness-like reaction in children: A retrospective review","volume":"60","author":"Patel","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2021111108254856100_CIT0021","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/oxfordjournals.aje.a115663","article-title":"Serum sickness in children after antibiotic exposure: Estimates of occurrence and morbidity in a health maintenance organization population","volume":"132","author":"Heckbert","year":"1990","journal-title":"Am J Epidemiol"},{"issue":"6","key":"2021111108254856100_CIT0022","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1651-2227.1986.tb10324.x","article-title":"Serum-sickness-like disease is a common cause of acute arthritis in children","volume":"75","author":"Kunnamo","year":"1986","journal-title":"Acta Paediatr Scand"},{"issue":"6","key":"2021111108254856100_CIT0023","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0009-9236(98)90093-5","article-title":"Serum sickness-like reaction to cefaclor: Lack of in vitro cross-reactivity with loracarbef","volume":"63","author":"Kearns","year":"1998","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"2021111108254856100_CIT0024","doi-asserted-by":"crossref","first-page":"e160033","DOI":"10.1001\/jamapediatrics.2016.0033","article-title":"Assessing the diagnostic properties of a graded oral provocation challenge for the diagnosis of immediate and nonimmediate reactions to amoxicillin in Children","volume":"170","author":"Mill","year":"2016","journal-title":"JAMA Pediatr"},{"issue":"3","key":"2021111108254856100_CIT0025","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/j.jaad.2011.02.037","article-title":"Serum sickness-like reaction: Histopathology and case report","volume":"65","author":"Tolpinrud","year":"2011","journal-title":"J Am Acad Dermatol"}],"container-title":["Paediatrics &amp; Child Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pch\/article-pdf\/26\/7\/428\/41128470\/pxab003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pch\/article-pdf\/26\/7\/428\/41128470\/pxab003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T14:18:35Z","timestamp":1671805115000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pch\/article\/26\/7\/428\/6209471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,3]]},"references-count":25,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,4,3]]},"published-print":{"date-parts":[[2021,11,11]]}},"URL":"https:\/\/doi.org\/10.1093\/pch\/pxab003","relation":{},"ISSN":["1205-7088","1918-1485"],"issn-type":[{"value":"1205-7088","type":"print"},{"value":"1918-1485","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11,1]]},"published":{"date-parts":[[2021,4,3]]}}}